Clinically significant drug interactions with atypical antipsychotics

Keyphrases

• Additive Effect 9%
• Adverse Events 18%
• Anti-infective Agents 9%
• Antidepressants 9%
• Antiepileptic Drugs 27%
• Atypical Antipsychotics 100%
• Bipolar Disorder 9%
• Carbamazepine 9%
• Clinical Case Reports 9%
• Clinical Efficacy 9%
• Clinical Reports 9%
• Clinically Significant 100%
• Co-administered Drugs 9%
• Competitive Effect 9%
• Cytochrome P450 (CYP450) 9%
• Cytochrome P450 1A2 (CYP1A2) 9%
• Cytochrome P450 Enzymes 9%
• Dose Dependence 9%
• Drug Absorption 18%
• Drug Discovery 9%
• Drug Interactions 100%
• Drug Monitoring 9%
• Drug Transporters 9%
• Fluoroquinolones 9%
• Inducer 9%
• Lurasidone 9%
• Mood Stabilizers 9%
• Patients with Schizophrenia 9%
• Pharmaceutical Interactions 9%
• Pharmaceutical Mechanism 9%
• Pharmacodynamic Interactions 9%
• Pharmacodynamic Mechanism 9%
• Pharmacokinetic Drug Interactions 9%
• Pharmacokinetic Profile 9%
• Pharmacokinetics-pharmacodynamics (PK-PD) 9%
• Phase II Metabolism 9%
• Phenobarbital 9%
• Phenytoin 9%
• Plasma Concentration 9%
• Plasma Drug Concentration 9%
• Plasma Parameters 9%
• Preclinical Development 9%
• Protease Inhibitors 9%
• Psychiatric Patients 9%
• Psychotic 9%
• Receptor Sites 9%
• Second-generation Antipsychotics 90%
• Site Activity 9%
• Therapeutic Drug Monitoring 9%
• Therapeutic Plasma 9%
• Therapeutic Treatment 9%
• Time Dependence 9%
• Treatment Efficacy 9%
• Treatment Interventions 9%
• Valproate 9%
• Ziprasidone 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Adverse Event 20%
• Anticonvulsive Agent 20%
• Antidepressant 10%
• Antiinfective Agent 10%
• Atypical Antipsychotics 100%
• Bioavailability 10%
• Bipolar Disorder 10%
• Carbamazepine 10%
• Clinical Study 10%
• Combination Therapy 10%
• CYP1A2 10%
• Cytochrome P450 10%
• Cytochrome P450 Inducer 10%
• Cytochrome P450 Inhibitor 10%
• Drug Absorption 20%
• Drug Concentration 10%
• Drug Discovery 10%
• Drug Interaction 100%
• Drug-Drug Interaction 10%
• Lurasidone 10%
• Mood Stabilizer 10%
• Pharmacodynamics 30%
• Pharmacokinetics 30%
• Phenobarbital 10%
• Phenytoin 10%
• Proteinase Inhibitor 10%
• Quinolone Derivative 10%
• Receptor 10%
• Selective Serotonin Reuptake Inhibitor 10%
• Sodium Valproate 10%
• Therapeutic Drug Monitoring 10%
• Ziprasidone 10%